Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
5
Teradata Corp
TDC
US OptionsDetailed Quotes
JAZZ250516P175000
- 0.00
- 0.000.00%
15min DelayClose Apr 24 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest175.00Strike Price0.00Turnover98.42%IV-60.58%PremiumMay 16, 2025Expiry Date66.02Intrinsic Value100Multiplier21DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9777Delta0.0034Gamma1.65Leverage Ratio-0.0227Theta-0.0323Rho-1.61Eff Leverage0.0134Vega
Jazz Pharmaceuticals Newsroom
TD Cowen Maintains Jazz Pharmaceuticals(JAZZ.US) With Buy Rating, Maintains Target Price $205
Needham Maintains Jazz Pharmaceuticals(JAZZ.US) With Buy Rating, Maintains Target Price $210
Jazz Pharmaceuticals Price Target Maintained With a $210.00/Share by Needham
Jazz Pharmaceuticals Analyst Ratings
UBS Maintains Jazz Pharmaceuticals(JAZZ.US) With Buy Rating, Cuts Target Price to $166
RBC Capital Maintains Jazz Pharmaceuticals(JAZZ.US) With Buy Rating, Raises Target Price to $182
RBC Raises Price Target on Jazz Pharmaceuticals to $182 From $178, Keeps Outperform Rating
Jefferies Maintains Jazz Pharmaceuticals(JAZZ.US) With Buy Rating, Maintains Target Price $183
BofA Securities Maintains Jazz Pharmaceuticals(JAZZ.US) With Buy Rating, Maintains Target Price $213
Jazz Pharmaceuticals (JAZZ) Gets a Buy From Jefferies
BofA Securities Maintains Jazz Pharmaceuticals(JAZZ.US) With Buy Rating, Announces Target Price $213
H.C. Wainwright Maintains Jazz Pharmaceuticals(JAZZ.US) With Buy Rating, Raises Target Price to $217
Jazz Pharmaceuticals Analyst Ratings
TD Cowen Maintains Jazz Pharmaceuticals(JAZZ.US) With Buy Rating, Maintains Target Price $205
UBS Upgrades Jazz Pharmaceuticals to Buy, Raises Price Target to $179
TD Cowen Sticks to Their Buy Rating for Jazz Pharmaceuticals (JAZZ)
Morgan Stanley Initiates Jazz Pharmaceuticals(JAZZ.US) With Buy Rating, Announces Target Price $183
UBS Upgrades Jazz Pharmaceuticals(JAZZ.US) to Buy Rating, Raises Target Price to $179
Positive Outlook for Jazz Pharmaceuticals: Buy Rating Backed by Strong Growth Prospects and Strategic Focus
Truist Financial Maintains Jazz Pharmaceuticals(JAZZ.US) With Buy Rating, Announces Target Price $230
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call